Kamlesh Kumar Pant appointed as chairman of NPPA
He is 1993-batch IAS officer of Himachal Pradesh cadre
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India lags behind in terms of commercially-oriented innovation, R&D and discovery of drug…
Inefficient clinical research, low productivity, low learning and study curve, lack of facilities and trained investigators, etc.…
Cadila Healthcare’s net profit rises 29 per cent in Q1
Consolidated total revenue from operations stood at Rs 4,025.4 crores for the quarter under consideration against Rs 3,514.6…
CDSCO approves study on mixing of Covaxin and Covishield doses
"The aim of the study is to assess the feasibility on whether a person can be given two different vaccine shots -- one each of…
Antibody levels predictive of Moderna’s vaccine efficacy, says study
The study, which has not yet been peer-reviewed, found that the Moderna vaccine was more effective in vaccine recipients with high…
Centre approves Bharat Biotech’s Ankleshwar plant for Covaxin production: Mandaviya
In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its…
NPPA puts cap on trade margin of 42 non-scheduled anti-cancer medicines
The key principles of price regulation by NPPA are the essentiality of drugs, control of prices of formulations and market-based…
NIH launches study of third COVID-19 vaccine dose in kidney transplant recipients
The trial will assess antibody response in people who did not respond to two-dose regimen
7th edition of PharmaLytica Expo to take place in Hyderabad on 13th August
The expo will bring together pharma companies, eminent speakers, a knowledge forum and networking opportunities under a hybrid…
Lincoln Pharmaceuticals reports standalone net profit of Rs 17.38 crores in Q1FY22
EBITDA for Q1FY22 was reported at Rs 26.31 crores, a rise of 17.37 per cent as compared to EBITDA of Rs 22.42 crores in Q1FY21